Omnicell, Inc. (OMCL)
NASDAQ: OMCL · Real-Time Price · USD
25.78
+0.39 (1.54%)
At close: May 9, 2025, 4:00 PM
26.00
+0.22 (0.85%)
After-hours: May 9, 2025, 7:50 PM EDT
Omnicell Market Cap
Omnicell has a market cap or net worth of $1.21 billion as of May 9, 2025. Its market cap has decreased by -4.12% in one year.
Market Cap
1.21B
Enterprise Value
1.21B
1-Year Change
-4.12%
Ranking
Category
Stock Price
$25.78
Market Cap Chart
Since August 9, 2001, Omnicell's market cap has increased from $181.10M to $1.21B, an increase of 566.83%. That is a compound annual growth rate of 8.31%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 9, 2025 | 1.21B | -41.44% |
Dec 31, 2024 | 2.06B | 20.51% |
Dec 29, 2023 | 1.71B | -24.00% |
Dec 30, 2022 | 2.25B | -71.61% |
Dec 31, 2021 | 7.93B | 56.15% |
Dec 31, 2020 | 5.08B | 48.16% |
Dec 31, 2019 | 3.43B | 41.23% |
Dec 31, 2018 | 2.43B | 31.91% |
Dec 29, 2017 | 1.84B | 48.60% |
Dec 30, 2016 | 1.24B | 12.43% |
Dec 31, 2015 | 1.10B | -6.62% |
Dec 31, 2014 | 1.18B | 29.70% |
Dec 31, 2013 | 909.20M | 84.27% |
Dec 31, 2012 | 493.40M | -10.09% |
Dec 30, 2011 | 548.80M | 15.22% |
Dec 31, 2010 | 476.30M | 27.66% |
Dec 31, 2009 | 373.10M | -2.41% |
Dec 31, 2008 | 382.30M | -58.83% |
Dec 31, 2007 | 928.70M | 77.54% |
Dec 29, 2006 | 523.10M | 66.86% |
Dec 30, 2005 | 313.50M | 12.69% |
Dec 31, 2004 | 278.20M | -26.34% |
Dec 31, 2003 | 377.70M | 547.86% |
Dec 31, 2002 | 58.30M | -69.70% |
Dec 31, 2001 | 192.40M | 6.24% |
View and export this data all the way back to 2001.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 659.45B |
Johnson & Johnson | 371.06B |
UnitedHealth Group | 345.29B |
AbbVie | 326.55B |
Novo Nordisk | 297.79B |
Abbott Laboratories | 231.82B |
Novartis AG | 214.71B |
AstraZeneca | 211.14B |